Endpoints studied in female cohorts
Where peer-reviewed research has used female-biology endpoints, the literature is concentrated. We curate compounds whose mechanism has at least one published touchpoint with that body of work.
Researcher access
MsAmino sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the FDA. Full disclaimer.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a synthetic analogue of the human GLP-1 hormone. For Research Use Only.
For research use only. Not for human consumption.
Women's research notes
A brief survey of the published touchpoints behind Semaglutide's inclusion in the women-focused research catalog. Not exhaustive, not clinical guidance — a starting point for designing your own protocol.
Where peer-reviewed research has used female-biology endpoints, the literature is concentrated. We curate compounds whose mechanism has at least one published touchpoint with that body of work.
Many of the most-cited pathways were first characterized in mixed-sex models. We surface the subset whose downstream readouts have been studied with a female-biology orientation.
Every batch ships with a third-party Certificate of Analysis: identity by mass spectrometry, purity by HPLC, batch-traceable. Research starts with a known compound.
Per-product reference lists land in a follow-up pass. Until then, the catalog page links the underlying mechanism literature.
MetabolicCagrilintide is a long-acting amylin analogue peptide being investigated for metabolic research applications. For Research Use Only.
MetabolicAOD-9604 is a modified fragment of human growth hormone (HGH).
MetabolicGLP-3 R is a next-generation GLP receptor agonist peptide for advanced metabolic research. For Research Use Only.